Study: Pediatric IBD complications linked to aggressive treatment

03/10/2014 | Healio (free registration)

An international survey of pediatric gastroenterologists found treating children with inflammatory bowel disease usually does not lead to complications such as death or malignancy but those that do occur most commonly are related to aggressive therapy. The study team said pediatric IBD patients receive aggressive therapies, such as immunosuppressants and biologics, because their disease tends to be more severe than IBD in adults, so there is increasing concern that overly aggressive treatment may increase risks of cancer and death.

View Full Article in:

Healio (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC